Screener
Axsome Therapeutics AXSM Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's asset turnover?
- Axsome Therapeutics (AXSM) reported asset turnover of 1.1× in Q1 2026.
- How has Axsome Therapeutics's asset turnover changed year-over-year?
- Axsome Therapeutics's asset turnover increased by 42.9% year-over-year, from 0.8× to 1.1×.
- What is the long-term trend for Axsome Therapeutics's asset turnover?
- Over 3 years (2022 to 2025), Axsome Therapeutics's asset turnover has grown at a 62.0% compound annual growth rate (CAGR), from 0.2× to 1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Axsome Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude